Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer.
Spitaleri G, Matei DV, Curigliano G, Detti S, Verweij F, Zambito S, Scardino E, Rocco B, Nolè F, Ariu L, De Pas T, de Braud F, De Cobelli O.
Spitaleri G, et al. Among authors: matei dv.
Ann Oncol. 2009 Mar;20(3):498-502. doi: 10.1093/annonc/mdn650. Epub 2009 Jan 12.
Ann Oncol. 2009.
PMID: 19139180
Free article.
Clinical Trial.